RONALD LUBER: Open Payments
NPI 1598794968 · RICHBORO, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 35 payments from 10 companies in 2025. Trend: 2023 $814 · 2024 $741 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $189 |
| ABBVIE INC. | 14 | $179 |
| Janssen Biotech, Inc. | 1 | $121 |
| PFIZER INC. | 1 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Lilly USA, LLC | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Indivior Inc. | 1 | $15 |
| Braeburn Inc. | 1 | $14 |
Products named: REXULTI, VRAYLAR, TREMFYA, NURTEC ODT, CAPLYTA, MOUNJARO, VOQUEZNA, Symbravo.
Industry payments across PA — which companies pay providers there.
